Skye Bioscience

Forecast & Rating6 analysts currently cover Skye Bioscience, with about 50.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $7.60, about 2614.3% upside from the current price of $0.28. Price targets range from $2.00 to $20.00 — a wide spread, showing clear disagreement over just how much Skye Bioscience can rise. Historically, about 10.6% of past price targets were eventually met, which adds credibility. For you, this means institutional views on Skye Bioscience are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Aug 17, 2026; for reference only and not investment advice.